Literature DB >> 7270602

Giardiasis in pregnancy.

A K Kreutner, V E Del Bene, M S Amstey.   

Abstract

Giardiasis in pregnancy can be a debilitating disease with threatens the well-being of mother and fetus, as illustrated by three cases. The usual therapeutic agents are contraindicated in pregnancy. Paromomycin, an oral, poorly absorbed aminoglycoside, is an alternate, potentially less toxic agent for treatment of symptomatic giardiasis in pregnancy. The pharmacologic actions of paromomycin in human beings and its antiprotozoan efficacy are discussed.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7270602     DOI: 10.1016/0002-9378(81)90082-x

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  7 in total

1.  Human colostrum action against Giardia lamblia infection influenced by hormones and advanced maternal age.

Authors:  Queli Lisiane Castro Pereira; Cristiane de Castro Pernet Hara; Rubian Trindade Silva Fernandes; Danny Laura Gomes Fagundes; Aline do Carmo França-Botelho; Maria Aparecida Gomes; Eduardo Luzía França; Adenilda Cristina Honorio-França
Journal:  Parasitol Res       Date:  2018-04-14       Impact factor: 2.289

Review 2.  Treatment of giardiasis.

Authors:  T B Gardner; D R Hill
Journal:  Clin Microbiol Rev       Date:  2001-01       Impact factor: 26.132

Review 3.  Human antiprotozoal therapy: past, present, and future.

Authors:  M Khaw; C B Panosian
Journal:  Clin Microbiol Rev       Date:  1995-07       Impact factor: 26.132

Review 4.  The biology of Giardia spp.

Authors:  R D Adam
Journal:  Microbiol Rev       Date:  1991-12

Review 5.  Giardiasis.

Authors:  M S Wolfe
Journal:  Clin Microbiol Rev       Date:  1992-01       Impact factor: 26.132

6.  Effect of resin disinfectants-I3 and -I5 on Giardia muris and Giardia lamblia.

Authors:  G L Marchin; L R Fina; J L Lambert; G T Fina
Journal:  Appl Environ Microbiol       Date:  1983-11       Impact factor: 4.792

7.  High resistance of Pseudomonas aeruginosa to paromomycin, an agent used for selective bowel decontamination (SBD).

Authors:  Florian Daxboeck; Werner Rabitsch; Maria Stadler; Ojan Assadian; Johannes Leitgeb
Journal:  GMS Hyg Infect Control       Date:  2013-04-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.